US Stock MarketDetailed Quotes

RVMD Revolution Medicines

Watchlist

40.200
+1.010+2.58%

Close May 3 16:00 ET

40.980
+0.780+1.94%

Post 17:17 ET

6.85BMarket Cap-10414P/E (TTM)

Revolution Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-56.23%-350.57M

-95.12%-120.56M

-94.25%-100.5M

-20.47%-67.12M

-13.11%-62.39M

-52.47%-224.4M

-57.36%-61.79M

-41.40%-51.74M

-63.48%-55.72M

-48.10%-55.16M

Net income from continuing operations

-75.46%-436.37M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.3M

-18.13%-68.1M

-32.93%-248.71M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

-55.07%-57.65M

Operating gains losses

778.95%167K

--166K

--0

-94.74%1K

-84.03%19K

--0

--19K

Depreciation and amortization

-3.59%9.31M

9.97%2.86M

-11.84%2.15M

-24.04%1.77M

10.61%2.53M

31.70%9.66M

26.04%2.6M

38.95%2.43M

26.78%2.33M

36.47%2.29M

Change In working capital

372.46%36.75M

255.51%21.16M

-122.41%-2.73M

529.54%21.28M

58.55%-2.95M

-254.62%-13.49M

-420.47%-13.6M

56.64%12.18M

-308.90%-4.95M

-25.49%-7.11M

-Change in receivables

172.21%3.42M

-453.93%-945K

221.78%2.2M

716.18%1.49M

24.18%678K

170.69%1.26M

-82.00%267K

177.29%684K

-123.24%-241K

146.63%546K

-Change in prepaid assets

29.98%-2.65M

-149.11%-2.25M

-204.32%-870K

80.37%-1.14M

147.16%1.61M

-2,008.59%-3.78M

618.81%4.59M

20.17%834K

-4,801.63%-5.78M

-171.76%-3.42M

-Change in payables and accrued expense

436.26%47.14M

502.73%18.01M

-8.80%8.16M

243.22%23.77M

-7.52%-2.8M

-19.79%8.79M

-170.82%-4.47M

365.11%8.94M

89.67%6.93M

-179.91%-2.61M

-Change in other current assets

37.07%-1.41M

445.25%7.08M

-5,568.63%-8.67M

23.94%88K

178.95%90K

-2,874.07%-2.25M

-2,632.10%-2.05M

---153K

--71K

---114K

-Change in other current liabilities

47.48%-1.38M

40.00%-699K

-45.24%322K

36.38%-1.5M

59.94%499K

-98.79%-2.62M

-35.31%-1.17M

272.94%588K

-686.96%-2.35M

70.49%312K

-Change in other working capital

43.80%-8.37M

99.60%-43K

-400.93%-3.87M

59.85%-1.43M

-64.76%-3.03M

-796.51%-14.89M

-215.59%-10.77M

-79.87%1.29M

-66.84%-3.57M

26.35%-1.84M

Cash from discontinued investing activities

Operating cash flow

-56.23%-350.57M

-95.12%-120.56M

-94.25%-100.5M

-20.47%-67.12M

-13.11%-62.39M

-52.47%-224.4M

-57.36%-61.79M

-41.40%-51.74M

-63.48%-55.72M

-48.10%-55.16M

Investing cash flow

Cash flow from continuing investing activities

-1,320.63%-342.6M

-5,254.76%-380.4M

162.66%77.35M

-169.78%-43.54M

-90.92%4M

83.03%-24.12M

-183.25%-7.1M

-309.05%-123.44M

150.82%62.4M

1,806.67%44.03M

Net PPE purchase and sale

28.54%-7.73M

19.44%-2.32M

28.09%-2.54M

55.70%-1.12M

6.93%-1.76M

-65.69%-10.82M

-143.11%-2.88M

-676.43%-3.53M

-92.53%-2.53M

47.22%-1.89M

Net investment purchase and sale

-2,417.81%-334.87M

-8,842.41%-378.09M

166.62%79.89M

-165.34%-42.43M

-87.47%5.75M

90.19%-13.3M

-143.52%-4.23M

-303.44%-119.91M

153.45%64.93M

679.79%45.91M

Cash from discontinued investing activities

Investing cash flow

-1,320.63%-342.6M

-5,254.76%-380.4M

162.66%77.35M

-169.78%-43.54M

-90.92%4M

83.03%-24.12M

-183.25%-7.1M

-309.05%-123.44M

150.82%62.4M

1,806.67%44.03M

Financing cash flow

Cash flow from continuing financing activities

307.79%1.23B

1,534.16%839.35M

-99.59%1.01M

4,422.74%64.63M

106,196.72%324.21M

2.47%301.43M

378.78%51.36M

77,747.96%248.34M

64.63%1.43M

-99.89%305K

Net common stock issuance

29.43%385.76M

--0

--62.05M

--323.71M

2.34%298.05M

394.44%49.92M

--248.13M

--0

Proceeds from stock option exercised by employees

98.30%6.63M

81.60%2.55M

383.73%1.01M

80.34%2.58M

63.61%499K

-0.51%3.35M

32.77%1.4M

-34.48%209K

-0.21%1.43M

-45.05%305K

Net other financing activities

1,992,300.00%836.81M

----

109.91%42K

----

Cash from discontinued financing activities

Financing cash flow

307.79%1.23B

1,534.16%839.35M

-99.59%1.01M

4,422.74%64.63M

106,196.72%324.21M

2.47%301.43M

378.78%51.36M

77,747.96%248.34M

64.63%1.43M

-99.89%305K

Net cash flow

Beginning cash position

48.00%163.15M

99.69%360.79M

256.15%382.92M

331.53%428.96M

48.00%163.15M

4.63%110.23M

38.73%180.68M

-45.33%107.52M

-71.81%99.4M

4.63%110.23M

Current changes in cash

913.00%536.03M

2,030.45%338.39M

-130.25%-22.13M

-667.35%-46.04M

2,554.39%265.81M

983.88%52.92M

12.37%-17.53M

210.10%73.16M

105.20%8.11M

-104.38%-10.83M

End cash Position

328.55%699.18M

99.69%360.79M

256.15%382.92M

331.53%428.96M

48.00%163.15M

38.73%180.68M

-45.33%107.52M

-71.81%99.4M

Free cash flow

-52.33%-358.3M

-90.03%-122.88M

-86.44%-103.03M

-17.17%-68.24M

-12.45%-64.15M

-53.03%-235.22M

-59.87%-64.66M

-49.19%-55.26M

-64.56%-58.24M

-39.74%-57.05M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-56.23%-350.57M	-95.12%-120.56M	-94.25%-100.5M	-20.47%-67.12M	-13.11%-62.39M	-52.47%-224.4M	-57.36%-61.79M	-41.40%-51.74M	-63.48%-55.72M	-48.10%-55.16M
Net income from continuing operations	-75.46%-436.37M	-185.87%-161.54M	-47.87%-108.43M	-60.56%-98.3M	-18.13%-68.1M	-32.93%-248.71M	-7.27%-56.51M	-38.51%-73.33M	-38.20%-61.22M	-55.07%-57.65M
Operating gains losses	778.95%167K	--166K	--0	--0	-94.74%1K	-84.03%19K	--0	--0	--0	--19K
Depreciation and amortization	-3.59%9.31M	9.97%2.86M	-11.84%2.15M	-24.04%1.77M	10.61%2.53M	31.70%9.66M	26.04%2.6M	38.95%2.43M	26.78%2.33M	36.47%2.29M
Change In working capital	372.46%36.75M	255.51%21.16M	-122.41%-2.73M	529.54%21.28M	58.55%-2.95M	-254.62%-13.49M	-420.47%-13.6M	56.64%12.18M	-308.90%-4.95M	-25.49%-7.11M
-Change in receivables	172.21%3.42M	-453.93%-945K	221.78%2.2M	716.18%1.49M	24.18%678K	170.69%1.26M	-82.00%267K	177.29%684K	-123.24%-241K	146.63%546K
-Change in prepaid assets	29.98%-2.65M	-149.11%-2.25M	-204.32%-870K	80.37%-1.14M	147.16%1.61M	-2,008.59%-3.78M	618.81%4.59M	20.17%834K	-4,801.63%-5.78M	-171.76%-3.42M
-Change in payables and accrued expense	436.26%47.14M	502.73%18.01M	-8.80%8.16M	243.22%23.77M	-7.52%-2.8M	-19.79%8.79M	-170.82%-4.47M	365.11%8.94M	89.67%6.93M	-179.91%-2.61M
-Change in other current assets	37.07%-1.41M	445.25%7.08M	-5,568.63%-8.67M	23.94%88K	178.95%90K	-2,874.07%-2.25M	-2,632.10%-2.05M	---153K	--71K	---114K
-Change in other current liabilities	47.48%-1.38M	40.00%-699K	-45.24%322K	36.38%-1.5M	59.94%499K	-98.79%-2.62M	-35.31%-1.17M	272.94%588K	-686.96%-2.35M	70.49%312K
-Change in other working capital	43.80%-8.37M	99.60%-43K	-400.93%-3.87M	59.85%-1.43M	-64.76%-3.03M	-796.51%-14.89M	-215.59%-10.77M	-79.87%1.29M	-66.84%-3.57M	26.35%-1.84M
Cash from discontinued investing activities
Operating cash flow	-56.23%-350.57M	-95.12%-120.56M	-94.25%-100.5M	-20.47%-67.12M	-13.11%-62.39M	-52.47%-224.4M	-57.36%-61.79M	-41.40%-51.74M	-63.48%-55.72M	-48.10%-55.16M
Investing cash flow
Cash flow from continuing investing activities	-1,320.63%-342.6M	-5,254.76%-380.4M	162.66%77.35M	-169.78%-43.54M	-90.92%4M	83.03%-24.12M	-183.25%-7.1M	-309.05%-123.44M	150.82%62.4M	1,806.67%44.03M
Net PPE purchase and sale	28.54%-7.73M	19.44%-2.32M	28.09%-2.54M	55.70%-1.12M	6.93%-1.76M	-65.69%-10.82M	-143.11%-2.88M	-676.43%-3.53M	-92.53%-2.53M	47.22%-1.89M
Net investment purchase and sale	-2,417.81%-334.87M	-8,842.41%-378.09M	166.62%79.89M	-165.34%-42.43M	-87.47%5.75M	90.19%-13.3M	-143.52%-4.23M	-303.44%-119.91M	153.45%64.93M	679.79%45.91M
Cash from discontinued investing activities
Investing cash flow	-1,320.63%-342.6M	-5,254.76%-380.4M	162.66%77.35M	-169.78%-43.54M	-90.92%4M	83.03%-24.12M	-183.25%-7.1M	-309.05%-123.44M	150.82%62.4M	1,806.67%44.03M
Financing cash flow
Cash flow from continuing financing activities	307.79%1.23B	1,534.16%839.35M	-99.59%1.01M	4,422.74%64.63M	106,196.72%324.21M	2.47%301.43M	378.78%51.36M	77,747.96%248.34M	64.63%1.43M	-99.89%305K
Net common stock issuance	29.43%385.76M	--0	--0	--62.05M	--323.71M	2.34%298.05M	394.44%49.92M	--248.13M	--0	--0
Proceeds from stock option exercised by employees	98.30%6.63M	81.60%2.55M	383.73%1.01M	80.34%2.58M	63.61%499K	-0.51%3.35M	32.77%1.4M	-34.48%209K	-0.21%1.43M	-45.05%305K
Net other financing activities	1,992,300.00%836.81M	----	----	----	----	109.91%42K	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	307.79%1.23B	1,534.16%839.35M	-99.59%1.01M	4,422.74%64.63M	106,196.72%324.21M	2.47%301.43M	378.78%51.36M	77,747.96%248.34M	64.63%1.43M	-99.89%305K
Net cash flow
Beginning cash position	48.00%163.15M	99.69%360.79M	256.15%382.92M	331.53%428.96M	48.00%163.15M	4.63%110.23M	38.73%180.68M	-45.33%107.52M	-71.81%99.4M	4.63%110.23M
Current changes in cash	913.00%536.03M	2,030.45%338.39M	-130.25%-22.13M	-667.35%-46.04M	2,554.39%265.81M	983.88%52.92M	12.37%-17.53M	210.10%73.16M	105.20%8.11M	-104.38%-10.83M
End cash Position	328.55%699.18M	328.55%699.18M	99.69%360.79M	256.15%382.92M	331.53%428.96M	48.00%163.15M	48.00%163.15M	38.73%180.68M	-45.33%107.52M	-71.81%99.4M
Free cash flow	-52.33%-358.3M	-90.03%-122.88M	-86.44%-103.03M	-17.17%-68.24M	-12.45%-64.15M	-53.03%-235.22M	-59.87%-64.66M	-49.19%-55.26M	-64.56%-58.24M	-39.74%-57.05M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall